With help from state, GSK adds jobs in Montana

"Good-paying" manufacturing and scientific jobs should be available as soon as GlaxoSmithKline ($GSK) upgrades a production facility in Hamilton, MT. A state development grant of $240,000 will help GSK buy equipment for a manufacturing plant.

The plant produces an adjuvant used in Cervarix, the company's cervical cancer vaccine that competes with Merck's ($MRK) Gardasil. Cervarix was approved for use in the U.S. in 2009.

Cervarix launched with a slower-than-expected start. But as it began to gain worldwide traction last year, the company began adding employees, according to the Missoulian. At that point, the goal was 30, with 10 being temporary jobs. With the grant, the temp jobs may become permanent, the paper says.

- see the story

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.